Generate Bio adds $370M for big push toward programmable protein medicines

Healthcare

AI, machine learning

Generate Biomedicines applies artificial intelligence and machine learning to protein analysis, which it uses to program its protein therapies for particular applications. The startup now has $370 million in financing to rapidly scale up operations, with a goal of reaching the clinic within two years.

Leave a Reply